Safilo Group S.p.A.

Safilo Group S.p.A. is actively involved in the design, manufacture, and both wholesale and retail dissemination of eyewear products. Its operations span North America, Europe, the Asia Pacific region, and numerous other international markets. The company's product line encompasses a variety of items such as optical frames, sunglasses, sports goggles, and helmets, including prescription frames. These are offered through a diverse brand portfolio featuring both proprietary and licensed names. Its own brand collection includes Carrera, Polaroid, Safilo, Smith, Blenders Eyewear, Privé Revaux, Adensco, Chesterfield, Elasta, and Emozioni. Furthermore, Safilo distributes products under licensed brands such as Banana Republic, BOSS, Carolina Herrera, Chiara Ferragni, David Beckham, Dsquared2, Fossil, havaianas, HUGO, Isabel Marant, Jimmy Choo, Juicy Couture, Kate Spade, LEVI'S, Liz Claiborne, Marc Jacobs, Missoni, M Missoni, Moschino and Love Moschino, Pierre Cardin, PORTS, rag&bone, Rebecca Minkoff, Tommy Hilfiger, Tommy Jeans, and Under Armour. The company supplies its offerings to a wide array of customers and points of sale, including opticians, optometrists, ophthalmologists, major distribution chains, department stores, specialized retailers, stores owned by its licensors, duty-free outlets, and sports shops. Sales are conducted via an extensive network of independent distributor partners. Formerly known as Safilo Holding S.p.A., the company rebranded to Safilo Group S.p.A. in September 2005. Established in 1878, Safilo Group S.p.A. maintains its corporate headquarters in Padua, Italy.

Safilo Group S.p.A. trades as SFL.MI on MIL. The company is classified in Healthcare / Medical - Instruments & Supplies and reports in EUR.

The current profile places the business in Medical - Instruments & Supplies. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Safilo Group S.p.A. can be compared against peers such as Arterra Bioscience, EL.En. S.p.A., EuKedos S.p.A., Otofarma S.p.A., Philogen S.p.A., Pharmanutra S.p.A..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of €671.14M, beta of 1.02, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SFL.MI currently shows total debt of N/A and beta of 1.02. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.safilogroup.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.